| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |